JOHN LASZLO, M.D.
This content is PDF only. Please click on the PDF icon to access.
"Let the jury consider the verdict," the King said, for about the twentieth time that day. "No, no!" said the Queen. "Sentence first—verdict afterwards." (1)
It would be a challenge even to Alice to find a way through the issues of science, regulation, and public welfare in the topsy-turvy world of medicinal uses of marijuana and its derivatives.
An elegant study reported in this issue by Chang and associates (2) tested the efficacy of a purified synthetic derivative of marijuana, delta-9-tetrahydrocannabinol (THC), as an antiemetic for a group of young patients receiving methotrexate treatment for osteogenic sarcoma. During repeated courses
LASZLO J. Tetrahydrocannabinol: From Pot to Prescription?. Ann Intern Med. 1979;91:916–918. doi: 10.7326/0003-4819-91-6-916
Download citation file:
Published: Ann Intern Med. 1979;91(6):916-918.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use